Indoco Remedies Share Price Today

Indoco Remedies incorporates wholly owned subsidiary Warren Lifesciences

Indoco Remedies incorporated Warren Lifesciences Private Limited on September 26, 2026. The subsidiary is wholly owned with an authorised capital of ₹1,00,000. Warren Lifesciences will focus on manufacturing active pharmaceutical ingredients and finished formulations.

Indoco Remedies approves incorporation of Warren Lifesciences subsidiary

Indoco Remedies approved the incorporation of wholly owned subsidiary Warren Lifesciences Private Limited. The entity will focus on manufacturing and selling pharmaceutical products including APIs and formulations. Initial authorized and paid-up capital is set at ₹1,00,000 with shares valued at ₹10 each. Name approval has been received from the Registrar of Companies, Mumbai.

Indoco Remedies discloses voting results of 79th AGM held September 17

Indoco Remedies disclosed voting results of its 79th AGM held on September 17, 2026, via Video Conferencing. The submission was made in compliance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Remote e-voting was open from September 13, 2026 at 9:00 am to September 16, 2026 at 5:00 pm. CS Ajit Sathe of M/s. A. Y. Sathe & Co. served as scrutinizer for the electronic voting process. Results and scrutinizer's report have been uploaded on the company's website and on the MUFG Intime India Private Limited portal.

Indoco Remedies approves ₹0.20 dividend, higher borrowing limits at AGM

Final dividend of ₹0.20 per equity share approved for FY26. Shareholders authorized increased borrowing limits and asset sales. Ms. Aditi Panandikar re-appointed as Managing Director. Dr. Vasudha Kamat continues as independent director beyond age 75.

Indoco Remedies clears UK MHRA CGMP inspection at Goa facility

Indoco Remedies' Goa facility completed a UK MHRA CGMP inspection with no critical or major observations. The inspection was conducted by the UK Medicines and Healthcare products Regulatory Agency. The clean outcome indicates the facility's compliance with UK manufacturing quality standards.

Indoco Remedies promoters acquire 38,930 shares in open market

Promoters acquired 38,930 equity shares in the open market on September 8 and 9, 2026. Total promoter holding rose to 67,42,542 shares, or 7.30% of the voting capital. Aruna Suresh Kare entered the register with 14,526 shares; others increased holdings modestly. No shares are encumbered by pledge or lien within the promoter group. Disclosure filed under Regulation 29(2) of SEBI (SA) Regulations, 2011.